Butyl-based reversed-phase high-performance liquid chromatography and silica normal-phase high-performance thin-layer chromatography methods for the determination of palonosetron in the presence of degradation products and dosage form additives
- 27 April 2020
- journal article
- research article
- Published by Springer Nature in JPC – Journal of Planar Chromatography – Modern TLC
- Vol. 33 (2) , 149-160
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Reversed Phase Liquid Chromatography2015
- Development of forced degradation and stability indicating studies of drugs—A reviewJournal of Pharmaceutical Analysis, 2014
- Liquid chromatography–electrospray quadrupole linear ion trap mass spectrometry method for the quantitation of palonosetron in human plasma and urine: Application to a pharmacokinetic studyJournal of Chromatography B, 2012
- Determination of palonosetron in human plasma by ultra performance liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic studyJournal of Pharmaceutical and Biomedical Analysis, 2012
- Development and validation of a stability-indicating LC method for determining Palonosetron hydrochloride, its related compounds and degradation products using naphthalethyl stationary phaseJournal of Pharmaceutical and Biomedical Analysis, 2011
- Determination of Palonosetron in Human Urine by LC–MS/MSBioanalysis, 2011
- Validated Chiral LC Method for the Enantiomeric Separation of Palonosetron HydrochlorideChromatographia, 2008
- Sensitive and Selective LC-MS-MS Assay for the Quantification of Palonosetron in Human Plasma and Its Application to a Pharmacokinetic StudyChromatographia, 2008
- Determination of palonosetron in human plasma by liquid chromatography–electrospray ionization-mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Enantioseparation of palonosetron hydrochloride by micellar electrokinetic chromatography with sodium cholate as chiral selectorJournal of Chromatography A, 2006